- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
December 20, 2024
From Benzinga
From Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
December 19, 2024
From Motley Fool
This Is Huge News for Eli Lilly Investors
December 19, 2024
From Motley Fool
Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer
December 18, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
From Benzinga
Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug
December 18, 2024
From Motley Fool
Eli Lilly Is Putting Dividend Growth Stocks to Shame With Yet Another Huge Increase to Its Payout
December 18, 2024
Tickers
LLY
From Motley Fool
2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious
December 15, 2024
Tickers
LLY
From Motley Fool
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
December 15, 2024
From Motley Fool
2 Weight Loss Stocks That Are Screaming Buys in December
December 15, 2024
Tickers
LLY
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
December 15, 2024
From Motley Fool
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
December 13, 2024
From Benzinga
From Benzinga
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
December 12, 2024
From Benzinga
Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound
December 12, 2024
From Benzinga
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
December 12, 2024
Tickers
LLY
From Motley Fool
2 No-Brainer Growth Stocks to Buy and Hold Through 2025 and Beyond
December 12, 2024
From Motley Fool
Eli Lilly's Investigational Cancer Drug Cuts Risk Of Death By 38% In Breast Cancer Patients
December 11, 2024
From Benzinga
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
December 10, 2024
Tickers
LLY
From Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
December 10, 2024
From Benzinga
As Eli Lilly Shares Gain Over 35% YTD, Drugmaker Announces $15B Share Buyback Program And Boosts Dividend By 15%
December 10, 2024
From Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
December 10, 2024
From Motley Fool
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
December 09, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.